The associations between components of metabolic syndrome (MetS) and mild cognitive impairment (MCI) subtypes remain unclear.
Objective:
The study aim was to identify the prevalence of MetS for MCI subtypes and to investigate sex differences in the association between MetS and MCI subtypes in older Japanese adults.
Methods:
The study analyzed data from 3,312 men and women aged 70 years or more. MetS was diagnosed according to International Diabetes Federation criteria. Participants completed cognitive tests and were categorized into normal cognition, amnestic MCI (aMCI), and non-amnestic MCI (naMCI). The associations between MetS and its components and MCI subtypes were analyzed using multiple logistic regression.
Results:
MetS prevalence was greater in participants with naMCI (men: p = 0.030; women: p = 0.040). Participants with naMCI showed higher odds ratios (OR) of MetS (men: 2.45, 95% confidence intervals (CI): 1.13–5.32; women: OR: 1.94, 95% CI: 1.12–3.39) compared with participants with normal cognition. MetS was not associated with aMCI. Analysis of MetS components showed that raised glucose (OR: 1.62, 95% CI: 1.19–2.22) and reduced high-density lipoprotein cholesterol (OR: 1.97, 95% CI: 1.25–3.12) were associated with naMCI in men. In women, raised blood pressure (OR: 1.42, 95% CI: 1.03–1.94) and raised glucose (OR: 1.32, 95% CI: 1.02–1.71) were associated with naMCI.
Conclusion:
MetS was associated only with naMCI regardless of sex, which suggests etiologic differences in MCI subtypes. We also found sex differences in the relationship between naMCI risk and MetS and its components.
Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (2001) Executive summary of the third report of The National Cholesterol Education Program (NCEP).
2.
AlbertiKG, EckelRH, GrundySM, ZimmetPZ, CleemanJI, DonatoKA, FruchartJC, JamesWP, LoriaCM, SmithSCJr; International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity (2009) Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation120, 1640–1645.
3.
LiuM, HeY, JiangB, WuL, WangJ, YangS, WangY (2015) Association between metabolic syndrome and mild cognitive impairment and its age difference in a Chinese community elderly population. Clin Endocrinol (Oxf)82, 844–853.
4.
FrisardiV, SolfrizziV, CapursoC, ImbimboBP, VendemialeG, SeripaD, PilottoA, PanzaF (2010) Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome?J Alzheimers Dis21, 57–63.
5.
VanhanenM, KoivistoK, MoilanenL, HelkalaEL, HanninenT, SoininenH, KervinenK, KesaniemiYA, LaaksoM, KuusistoJ (2006) Association of metabolic syndrome with Alzheimer disease: A population-based study. Neurology67, 843–847.
WinbladB, PalmerK, KivipeltoM, JelicV, FratiglioniL, WahlundLO, NordbergA, BackmanL, AlbertM, AlmkvistO, AraiH, BasunH, BlennowK, de LeonM, DeCarliC, ErkinjunttiT, GiacobiniE, GraffC, HardyJ, JackC, JormA, RitchieK, can DuijnC, VisserP, PetersenRC (2004) Mild cognitive impairment–beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med256, 240–246.
RobertsRO, GedaYE, KnopmanDS, ChaRH, BoeveBF, IvnikRJ, PankratzVS, TangalosEG, PetersenRC (2010) Metabolic syndrome, inflammation, and non-amnestic mild cognitive impairment in older persons: A population-based study. Alzheimer Dis Assoc Disord24, 11–18.
10.
RobertsRO, GedaYE, KnopmanDS, ChaRH, PankratzVS, BoeveBF, TangalosEG, IvnikRJ, RoccaWA, PetersenRC (2012) The incidence of MCI differs by subtype and is higher in men: The Mayo Clinic Study of Aging. Neurology78, 342–351.
11.
PetersenRC, RobertsRO, KnopmanDS, GedaYE, ChaRH, PankratzVS, BoeveBF, TangalosEG, IvnikRJ, RoccaWA (2010) Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology75, 889–897.
12.
TrollorJN, SmithE, BauneBT, KochanNA, CampbellL, SamarasK, CrawfordJ, BrodatyH, SachdevP (2010) Systemic inflammation is associated with MCI and its subtypes: The Sydney Memory and Aging Study. Dement Geriatr Cogn Disord30, 569–578.
13.
SkupM, ZhuH, WangY, GiovanelloKS, LinJA, ShenD, ShiF, GaoW, LinW, FanY, ZhangH; Alzheimer’s Disease Neuroimaging Study (2011) Sex differences in grey matter atrophy patterns among AD and aMCI patients: Results from ADNI. Neuroimage56, 890–906.
14.
ShimadaH, MakizakoH, LeeS, DoiT, LeeS, TsutsumimotoK, HaradaK, HottaR, BaeS, NakakuboS, HaradaK, SuzukiT (2016) Impact of cognitive frailty on daily activities in older persons. J Nutr Health Aging20, 729–735.
15.
FolsteinMF, FolsteinSE, McHughPR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res12, 189–198.
16.
HänninenT, HallikainenM, TuomainenS, VanhanenM, SoininenH (2002) Prevalence of mild cognitive impairment: A population-based study in elderly subjects. Acta Neurol Scand106, 148–154.
17.
JungwirthS, WeissgramS, ZehetmayerS, TraglKH, FischerP (2005) VITA: Subtypes of mild cognitive impairment in a community-based cohort at the age of 75 years. Int J Geriatr Psychiatry20, 452–458.
18.
YaffeK, MiddletonLE, LuiLY, SpiraAP, StoneK, RacineC, EnsrudKE, KramerJH (2011) Mild cognitive impairment, dementia, and their subtypes in oldest old women. Arch Neurol68, 631–636.
19.
MakizakoH, ShimadaH, DoiT, TsutsumimotoK, HottaR, NakakuboS, MakinoK, SuzukiT (2016), Comorbid mild cognitive impairment anddepressive symptoms predict future dementia in community olderadults: A 24-month follow-up longitudinal study. J Alzheimers Dis54, 1473–1482.
20.
MakizakoH, ShimadaH, ParkH, DoiT, YoshidaD, UemuraK, TsutsumimotoK, SuzukiT (2013) Evaluation of multidimensional neurocognitive function using a tablet personal computer: Test-retest reliability and validity in community-dwelling older adults. Geriatr Gerontol Int13, 860–866.
21.
AlbertiKG, ZimmetP, ShawJ (2006) Metabolic syndrome–a newworld-wide definition. A consensus statement from theInternational Diabetes Federation. Diabet Med23, 469–480.
World Health Organization (1995) Physical status. The use and interpretation of anthropometry. Report of a WHO expert consultation. WHO Technical Report Series Number 854. Geneva. World Health Organization.
24.
YaffeK, KanayaA, LindquistK, SimonsickEM, HarrisT, ShorrRI, TylavskyFA, NewmanAB (2004) The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA292, 2237–2242.
25.
MaF, WuT, ZhaoJ, JiL, SongA, ZhangM, HuangG (2016) Prevalence of mild cognitive impairment and its subtypes among Chinese older adults: Role of vascular risk factors. Dement Geriatr Cogn Disord41, 261–272.
26.
WallinA, MilosV, SjögrenM, PantoniL, ErkinjunttiT (2003) Classification and subtypes of vascular dementia. Int Psychogeriatr15, 27–37.
FrisoniGB, GalluzziS, BrescianiL, ZanettiO, GeroldiC (2002) Mild cognitive impairment with subcortical vascular features: Clinical characteristics and outcome. J Neurol249, 1423–1432.
29.
GalluzziS, SheuCF, ZanettiO, FrisoniGB (2005) Disstinctive clinical features of mild cognitive impairment with subcortical cerebrovascular disease. Dement Geriatr Cogn Disord19, 196–203.
30.
LuchsingerJA, ReitzC, PatelB, TangMX, ManlyJJ, MayeuxR (2007) Relation of diabetes to mild cognitive impairment. Arch Neurol64, 570–575.
31.
DimopoulosN, PiperiC, SaloniciotiA, PsarraV, MitsonisC, LiappasI, LeaRW, KalofoutisA (2007) Characterization of the lipid profile in dementia and depression in the elderly. J Geriatr Psychiatry Neurol20, 138–144.
32.
LeparaO, ValjevacA, AlajbegovićA, ZaciragićA, Nakas-IćindićE (2009) Decreased serum lipids in patientswith probable Alzheimer’s disease. Bosn J Basic Med Sci9, 215–220.
33.
YinZX, ShiXM, KrausVB, FitzgeraldSM, QianHZ, XuJW, ZhaiY, SerenyMD, ZengY (2012) High normal plasma triglycerides are associated with preserved cognitive function in Chinese oldest-old. Age Ageing41, 600–606.
34.
BanksWA, BurneyBO, RobinsonSM (2008) Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood-brain barrier. Peptides29, 2061–2065.
35.
UrayamaA, BanksWA (2008) Starvation and triglycerides reverse the obesity-induced impairment of insulin transport at the blood-brain barrier. Endocrinology149, 3592–3597.
36.
ChangGQ, KaratayevO, DavydovaZ, LeibowitzSF (2004) Circulating triglycerides impact on orexigenic peptides and neuronal activity in hypothalamus. Endocrinology145, 3904–3912.
37.
JaegerLB, FarrSA, BanksWA, MorleyJE (2002) Effects of orexin-A on memory processing. Peptides23, 1683–1688.
38.
CapelliniVK, BaldoCF, CelottoAC, BatalhãoME, CárnioEC, RodriguesAJ, EvoraPR (2010) Oxidative stress is notassociated with vascular dysfunction in a model of alloxan-induceddiabetic rats. Arq Bras Endocrinol Metabol54, 530–539.
39.
LiuCY, ZhouHD, XuZQ, ZhangWW, LiXY, ZhaoJ (2009) Metabolic syndrome and cognitive impairment amongst elderly people in Chinese population: A cross-sectional study. Eur J Neurol16, 1022–1027.
40.
YatesKF, SweatV, YauPL, TurchianoMM, ConvitA (2012) Impact of metabolic syndrome on cognition and brain: A selected review of the literature. Arterioscler Thromb Vasc Biol32, 2060–2067
41.
HassingLB, JohanssonB, NilssonSE, BergS, PedersenNL, GatzM, McClearnG (2002) Diabetes mellitus is a risk factor for vascular dementia, but not for Alzheimer’s disease: A population-based study of the oldest old. Int Psychogeriatr14, 239–248.
42.
ChengG, HuangC, DengH, WangH (2012) Diabetes as a risk factor for dementia and mild cognitive impairment: A meta-analysis of longitudinal studies. Intern Med J42, 484–491.
43.
YoshitakeT, KiyoharaY, KatoI, OhmuraT, IwamotoH, NakayamaK, OhmoriS, NomiyamaK, KawanoH, UedaK, SueishiK, TsuneyoshiM, FujishimaM (1995) Incidence and risk factors of vascular dementia and Alzheimer’s disease in a defined elderly Japanese population: The Hisayama Study. Neurology45, 1161–1168.
44.
PerrottaM, LemboG, CarnevaleD (2016) Hypertension and dementia: Epidemiological and experimental evidence revealing a detrimental relationship. Int J Mol Sci17, 347.
45.
HughesTM, CraftS, LopezOL (2015) Review of ‘the potential role of arterial stiffness in the pathogenesis of Alzheimer’s disease’. Neurodegener Dis Manag5, 121–135.
46.
LangbaumJB, ChenK, LaunerLJ, FleisherAS, LeeW, LiuX, ProtasHD, ReederSA, BandyD, YuM, CaselliRJ, ReimanEM (2012) Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons. Neurobiol Aging33, 827.e11–e19.
47.
OgberaAO (2010) Prevalence and gender distribution of the metabolic syndrome. Diabetol Metab Syndr2, 1.
48.
OlesenOF, DagøL (2000) High density lipoprotein inhibits assembly of amyloid beta-peptides into fibrils. BiochemBiophys Res Commun270, 62–66.
49.
vanExel E, de CraenAJ, GusseklooJ, HouxP, Bootsma-van der WielA, MacfarlanePW, BlauwGJ, WestendorpRG (2002) Association between high-density lipoprotein and cognitive impairment in the oldest old. Ann Neurol51, 716–721.
50.
NgTP, FengL, NyuntMS, FengL, GaoQ, LimML, CollinsonSL, ChongMS, LimWS, LeeTS, YapP, YapKB (2016) Metabolic syndrome and the risk of mild cognitive impairment and progression to dementia: Follow-up of the Singapore Longitudinal Ageing Study Cohort. JAMA Neurol73, 456–463.
